ArticleInternational journal of molecular sciences2018

Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice.

Wenyu Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.